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Abstract 
Microscopy performed on stained films of peripheral blood for detection, identification and quantification of malaria 
parasites is an essential reference standard for clinical trials of drugs, vaccines and diagnostic tests for malaria. The 
value of data from such research is greatly enhanced if this reference standard is consistent across time and geog-
raphy. Adherence to common standards and practices is a prerequisite to achieve this. The rationale for proposed 
research standards and procedures for the preparation, staining and microscopic examination of blood films for 
malaria parasites is presented here with the aim of improving the consistency and reliability of malaria microscopy 
performed in such studies. These standards constitute the core of a quality management system for clinical research 
studies employing microscopy as a reference standard. They can be used as the basis for the design of training and 
proficiency testing programmes as well as for procedures and quality assurance of malaria microscopy in clinical 
research.
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Background
Microscopy continues to play an important role in 
malaria diagnosis and in research studies. While the 
advent of rapid diagnostic tests have reduced its impor-
tance as a primary diagnostic test in routine practice in 
some countries, microscopy remains an essential tool to 
support clinical research, severe malaria case manage-
ment and monitoring of anti-malarial treatment efficacy 
[1]. In the specific context of drug efficacy trials, assess-
ments of in-use and new drugs depend on high-quality 
microscopy to differentiate Plasmodium species and 
stages, and estimate parasite density [2]. Microscopy is 
likely to remain relevant in drug efficacy monitoring as 
initial signs of resistance to anti-malarial drugs are com-
monly seen first through a reduction in parasite clearance 
rate [3, 4]. A particular case is that of resistance to arte-
misinins, since the only currently available method for its 
detection in  vivo is the measurement of parasite clear-
ance rates, a procedure that requires repeated accurate, 
precise, and standardized estimations of parasite density 
in peripheral blood. Furthermore, malaria vaccine trials 
commonly use malaria parasite detection by microscopy 
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as the endpoint [5], though this is increasingly being 
superseded by tests based on nucleic acid amplification. 
Finally, microscopy continues to be used as a reference 
standard for evaluation of other diagnostic tools [6]. 
In the absence of alternative validated field-applicable 
methods for malaria parasite detection, identification 
and quantification, microscopy will continue to be a 
mainstay of clinical and operational research in malaria 
in the medium to long term.
Standardization of methods enables direct compari-
sons of results from studies conducted at varying points 
in time and location while improving the quality and reli-
ability of results generated in individual studies. This is 
particularly relevant to preparing and staining slides and 
for the detection, identification and quantification of 
malaria parasites in thick and thin blood films given their 
importance in determining the endpoints and outcomes 
of malaria trials. Various factors beyond the quality of 
the blood film and the reading process can also influ-
ence microscopy results. These include stochastic vari-
ation such as the distribution of parasites throughout a 
film, the workload and expertise of readers, how slides 
are declared negative or parasite density is estimated, and 
how discrepant results are handled, all of which can influ-
ence outcomes, particularly relating to parasite quantita-
tion and detection of low-density infections.
Guidelines and procedures for quality assurance in 
malaria microscopy have already been published and 
are an excellent basis for standardizing and improving 
clinical malaria microscopy [7–10]. However, the stand-
ards which form the basis of the recommendations in 
these documents do not address the different, and in 
some respects more stringent, requirements of malaria 
microscopy for research. Whilst malaria diagnosis pri-
marily needs to ensure that a patient with fever caused 
by malaria parasites receives appropriate anti-malarial 
therapy, research requirements demand more stringent 
standards in assessing and confirming technical perfor-
mance. Research applications usually necessitate iden-
tification or exclusion of parasitaemia (as distinct from 
identification of malarial disease) with very high posi-
tive predictive value and accurate quantitation of para-
sites. The costs of false positive results may be relatively 
light in routine clinical settings as they would likely 
result in some unnecessary treatment of patients with 
anti-malarial drugs. However, incorrectly identifying 
new or continuing infection has major implications for 
determining the effectiveness of malaria vaccines and 
therapeutics.
The minimum quality assurance standards for research 
malaria microscopy proposed in this article would ena-
ble better comparison of results between studies con-
ducted by various institutions. The standards have been 
reviewed by a committee of experts under the auspices 
of the Special Programme for Research and Training in 
Tropical Diseases (TDR) at the World Health Organiza-
tion (WHO) and are the basis of the Research Malaria 
Microscopy Standards (ReMMS) manual [11]. An asso-
ciated tool, the ‘Obare Method Calculator’, enables ready 
incorporation of these methods into research studies. 
It is envisaged that adherence to such standards will 
greatly enhance the value of malaria research and sur-
veillance, and hence better guide the evolution of malaria 
programmes.
Study personnel
The generation of accurate, precise and reproducible 
microscopy data can only be accomplished from cor-
rectly prepared, stained and examined blood films, which 
in turn depend on the inputs of skilled, well-trained and 
motivated laboratory personnel. Attaining and main-
taining high standards in the preparation and staining of 
blood films should be routine given the availability of cor-
rect tools, standard operating procedures, and materials 
(see later sections of this article) but the examination of 
slides requires a different approach. A research micros-
copist is expected to be able to detect, identify and count 
human malaria parasites in Giemsa-stained peripheral 
blood films while reliably differentiating parasites from 
other features normally found in the film and from arte-
facts or debris that may be indistinguishable from para-
sites to the inexperienced eye. Extensive training and 
experience are required to attain the necessary level of 
proficiency, but it is hard to standardize their content 
and duration such that this level of proficiency can be 
assured. Work practices, workload and the working envi-
ronment can further affect microscopists’ performance. 
Minimum competency standards to be attained in formal 
testing as a pre-requisite to performing microscopy for 
research studies can however be defined with reference 
to the particular requirements of research microscopy.
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Standardized assessments for competency in malaria 
microscopy are currently based on a slide set described in 
the WHO Malaria Microscopy Quality Assurance Man-
ual [8]. This slide set and related proficiency standards 
were designed to meet the needs of quality assurance in 
national malaria control programmes wherein parasite 
detection and quantification of Plasmodium falcipa-
rum malaria parasites are of prime importance to ensure 
patients with malaria receive the most appropriate anti-
malarial treatment. The ‘competence level’ of micros-
copists is defined based on competence in detecting 
parasitaemia, species identification and parasite quanti-
fication, with no specific criteria defined for diagnostic 
sensitivity or specificity. As also indicated in the WHO 
Malaria Microscopy Quality Assurance Manual, special-
ized microscopy in clinical trials would require a more 
thorough assessment with an expanded slide set to obtain 
more robust estimates of sensitivity, specificity and other 
diagnostic performance criteria for each microscopist 
being tested.
The proposed slide set for assessing the competency of 
research microscopists comprises 130 slides (Box 1), and 
competence levels determined from assessments using 
this set are listed in Table 1. The most important change 
with respect to existing clinical microscopy guidelines 
follows from the critical importance of high specificity 
in research microscopy, given the disproportionate effect 
of a positive microscopy result during patient follow-
up on the estimated efficacy of an anti-malarial drug or 
vaccine. This is reflected in the introduction of a false 
positive rate criterion with stringent thresholds at each 
accreditation level (≤ 2.5% for false positives vs. ≤ 10% 
for false negatives at Level 1) and in the four-fold higher 
number of negative slides (80 vs. 20 in the set described 
in the Manual). The higher number of slides allows more 
robust estimates of sensitivity (Se) and specificity (Sp) 
(errors of < 10% if Se at 90% and < 5% if Sp at 97.5%) and 
the inclusion of poor-quality slides to test proficiency in 
slide quality assessment. The minimum requirements 
for numbers and types of slides defined in this set could 
be increased to improve the precision of the assessment 
metrics, but this needs to be balanced against practical-
ity given that a test with the slide set recommended here 
could take up to three days. However, given the size of 
investments in drug and vaccine development, this 
investment in assuring the quality of clinical trials should 
be seen as critical.
Demonstrated competency of malaria microscopists 
is one of several components of the process leading to 
high-quality research microscopy. The quality of equip-
ment and materials along with systematic quality control 
(QC) and feedback directly influence the performance of 
microscopists (see later sections) as does the volume of 
work. Microscopists’ performance and workloads need 
to be carefully monitored and managed to ensure that 
operator fatigue does not adversely affect the quality of 
microscopy. A research microscopist may be expected to 
read approximately 40 slides per day depending on the 
proportion of positive slides and on the parasite density 
on those slides. More precise estimates of ideal work-
loads have been calculated elsewhere, but would need 
to be adapted to take into account the expected num-
bers of positive slides at patient recruitment and on fol-
low-up according to the research protocol as well as the 
increased number of fields to be read before declaring a 
slide negative [8].
Table 1 Grades for certification of research malaria microscopists [11]
Competency level Detection 
of parasitaemia
Species identification Parasite quantification (± 25% 
of true count)
False positive rate
Level 1 ≥ 90% ≥ 90% ≥ 50% ≤ 2.5%
Level 2 80 to < 90% 80 to  < 90% 40 to  < 50% ≤ 5%
Level 3 70 to < 80% 70 to  < 80% 30 to  < 40% ≤ 10%
Level 4 < 70% < 70% < 30% > 10%
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BOX 1: Recommended slide set for Competence Assessment of Research Microscopists
Equipment and materials
Detailed lists of equipment and materials required for 
the preparation, staining and examination of slides have 
been published in various malaria microscopy guides and 
manuals [8, 9]. These have been supplemented with sug-
gested specifications where these are not already defined 
in existing manuals to facilitate consistent and stand-
ardized performance of research microscopy (Box  2). 
The use of Giemsa (stain) and buffers from reputable 
manufacturers, purchased as ready-made concentrates 
or in powder or tablet form, would help to reduce vari-
ation in slide staining quality. Similarly, using synthetic 
immersion oils which are colour-stable, non-corrosive 
and of controlled refractive index would help maintain 
the performance of the microscope and the quality of 
the microscopic images. Some specifications, such as 
the recommendation for using microscopes with ocu-
lar lenses of Field Number (FN) 20 and plan-achromat 
objectives, are those of microscopes commonly used in 
malaria diagnosis and have been used as the basis for 
procedural details for slide examination. Care must be 
taken to maintain the quality of equipment and materials 
after procurement—this implies storage of materials and 
equipment in appropriate conditions, use of materials 
before expiry dates if applicable, and in the case of micro-
scopes, ensuring routine care and preventive mainte-
nance is performed as described in previously published 
guides [9].
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BOX 2: Recommended equipment and materials 
for research malaria microscopy [11]
• Slide template (see Fig.  1): The template must be 
approximately 25 × 75  mm, i.e., same size as a slide 
and must have a circle of known diameter (e.g., 
12  mm) situated towards one end the template such 
that there is adequate space for labelling and for 
spreading the thin film on the slide
• Micropipette to measure 5–10 µL volumes
• Giemsa stain, buffer pH 7.2—commercial prepara-
tions preferable or methods from WHO manuals or 
standard operating procedures.
• pH meter calibrated for measurements at pH 7.2
• Synthetic immersion oil, refractive index 1.5
• Binocular microscopes with 10 × FN 20 oculars, 
100 × oil-immersion plan-achromat objective, inbuilt 
electric light source.
• Grid reticle (recommended if objectives are not of 
plan-achromat type).
BOX 3: Minimum requirements for preparing blood films 
and labelling slides
• Labelling minimum requirement: Study + subject ID, 
date and time of blood collection.
• Sampling: Blood from fingerprick or venepuncture 
is acceptable but should be consistent within a study 
and stated in the protocol and study report.
• Thick films to be spread using a known volume of 
blood spread over fixed area, e.g., use of micropipette 
to measure 6 µL of blood and a template to prepare 
thick films of 12 mm diameter.
• Thin films to be spread using 2–5 µL of blood to 
obtain a thin film with a feathered edge.
• Slides must be completely dried before staining—
e.g., minimum of 1  h at 37–40  °C (may need to be 
longer for anticoagulated blood) or overnight at ambi-
ent temperature with low humidity.
• Thin films to be fixed with absolute methanol.
Preparing blood films
Preparing standard thick blood films can be easily 
accomplished by spreading a known volume of blood 
over a defined area on a slide as has previously been rec-
ommended for reference slides for slide banks (see Fig. 1, 
Box 3) [8]. The use of micropipettes and slide templates 
make this procedure more consistent than those depend-
ing on visual checks of the size of the blood drops used to 
make the films and of the size and thickness of the films, 
thus reducing variability in blood film size and thick-
ness. The use of these aids offers the added advantage of 
making it easier to train microscopists to prepare stand-
ard thick blood films. Even with such aids however, the 
variation in the thickness of blood films cannot be com-
pletely eliminated, particularly at the edges of the blood 
film, thus requiring certain adaptations of thick film 
microscopy procedures as described in a later section of 
this paper. Further, such aids are of only limited utility in 
the standardization of thin blood films—blood volumes 
may need to be varied depending on the technique used 
or the viscosity of the blood, and the desired ‘feathered 
edge’, i.e., the monolayer of cells at the tail end of the film, 
can only be consistently achieved through practice.
Parasite loss is usually not seen from thin films since 
they are fixed with methanol before staining but meas-
ures need to be taken to enhance parasite detection and 
density estimations in the thick film, given reports of 
30–90% parasite loss during the staining process [12, 13]. 
Various methods based on acetone fixation, drying of 
films for more than 24 h or even abrasion of the slide sur-
face to improve adhesion of the thick film have previously 
been proposed to reduce or eliminate parasite loss [14]. 
In practice however, overnight drying at ambient tem-
perature with low humidity or gentle warming of slides 
to assist drying can minimize loss. Drying for longer 
durations may be required when preparing films from 
anticoagulated blood as they are more likely to slough off 
during rinsing after staining. Care must be taken to avoid 
excessive heat (sustained exposure at > 40 °C), which may 
cause heat-fixing of thick films and prevent dehaemoglo-
binization. Heparin-anticoagulated blood is not recom-
mended for making blood films as it may lead to a bluish 
background which may interfere with microscopy [15]. 
Anticoagulated blood samples must be spread as soon 
as possible, preferably within an hour of collection, to 
help maintain parasite morphology. It remains unclear 
whether there are differences in parasite detection and 
density between samples collected from capillary or 
venous blood. It is advisable to establish consistent pro-
cedures for blood collection within a single study and to 
report these in publications along with the other meth-
ods employed.
Finally, it is critical to ensure that slides can be une-
quivocally identified through correct, clear and consist-
ent labelling to be able to link the microscopy results 
to study subjects and other related data without which 
the conclusions from the research may not be reliable. 
At a minimum, slides must be labelled with a study and 
anonymized subject ID as well as the date and time of 
blood sample collection. Further aids to identifying slides 
and detecting and resolving errors in labelling include 
follow-up time-points and unique codes.
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Staining
All commonly used methods for staining blood films 
for malaria microscopy are based on the ‘Romanowsky 
effect’, wherein an acidic and a basic stain are combined 
to produce differential colouring of the parasite nucleus 
and cytoplasm [16]. The stain solutions may be purely 
aqueous, such as Field or Jaswant-Singh-Bhattacharjee 
(JSB) variants, or stains may also be dissolved in metha-
nol with glycerol to stabilize the concentrated stain solu-
tion. This modification, developed by Gustav Giemsa in 
1904, has become the most commonly used standard 
stain for malaria microscopy and is the method recom-
mended by the WHO [7, 10, 17]. Staining using aqueous 
stains can be performed in a few seconds which makes 
them useful for routine clinical applications especially in 
peripheral settings. However, stain quality can be incon-
sistent given that the procedure depends on dipping air-
dried blood films into the staining solutions for a few 
seconds. These methods are probably appropriate when 
only a few slides are stained per day since slides need to 
be stained individually. However, in research laboratory 
settings where staining of a consistently high quality is 
required to assist with accurate parasite identification 
and where workloads tend to be heavier, Giemsa staining 
using commercial stain and buffer preparations is gener-
ally preferred. This helps with making secondary mor-
phological characteristics, such as Maurer’s clefts in P. 
falciparum and Schüffner’s dots in P. vivax more clearly 
visible and allows for staining large numbers of slides 
simultaneously in batches at low cost per slide. The ‘slow’ 
staining method with 3–5% working Giemsa solution 
and 45–60  min of staining is recommended for slides 
that may need to be stored for long periods or require 
repeat reading [7, 8]. This is particularly relevant in the 
case of research studies where repeat reads are required 
for internal or external quality control (IQC or EQC), 
often with delays of weeks or months between initial and 
repeat reads. The ‘fast’ staining method with 10% Giemsa 
and 10–20 min, or even Field’s stain, can also be used in 
specific cases where a quick diagnosis is required, e.g. 
during subject screening, for symptomatic patients or 
when severe malaria is suspected, but a duplicate slide 
must also be prepared for slow staining. In all cases, slide 
racks must be used for staining and the use of Coplin jars 
or staining troughs is not recommended to obviate even 
the minimal possibility of transfer of parasites between 
slides.
Standardizing blood film interpretation
Malaria microscopy is a procedure for the detection, 
identification and quantification of parasites per unit 
volume of blood. This implies that a standard volume of 
blood must be examined before a slide can be declared 
negative or to be able to estimate the parasite density in a 
given blood sample. Some early researchers used the time 
spent to examine blood films as a way of standardizing 
the volume of blood examined [18]. While this may be 
acceptably consistent for detecting parasites for a given 
microscopist, the number of fields viewed is likely to be 
highly variable between different microscopists and labo-
ratories or even over time. Methods based on counting a 
set number of WBCs before declaring a slide negative are 
commonly used in clinical settings and counting parasites 
per set number of WBCs is perhaps the most commonly 
used method for parasite density estimation in research 
studies. This approach can reduce the effect of varying 
thickness of the blood film but is also dependent on the 
WBC count, which can vary significantly between indi-
viduals or over time. Variations in WBC counts in turn 
affect the volume of blood examined to detect parasites 
as well as estimates of parasite density if a simultaneously 
obtained true WBC count is not used [19]. If on the other 
hand the number of high power fields (HPF, 1000× mag-
nification) is standardized, the variability in the thickness 
of the blood film needs to be taken into consideration, 
whether it is due to varying technique when preparing 
the thick film or due to the slight unavoidable differences 
in thickness between the edges and the centre of even 
standard thick films prepared as described above. Very 
often a procedure is followed wherein the presence of 
parasites is assessed on the thick film per a set number of 
HPFs and the estimation of parasite density is begun as 
soon as the first parasite is seen by counting parasites and 
WBCs. This introduces a systematic bias towards higher 
estimates of parasite densities, particularly in low-density 
infections [20]. Thin films are not suitable for parasite 
detection at medium or low densities as parasites can 
most easily be seen where the film is the thinnest, i.e., at 
the tail end of the thin film, where hundreds of additional 
fields would need to be read to match the limit of detec-
tion or analytical sensitivity of the thick blood film [21].
For research applications, it is common to read up to 
200 HPFs or count up to 2000–2500 WBCs on the thick 
film before declaring a slide parasite-negative. This limit 
of detection is theoretically as low as 3–4 parasites per 
µL (see Table  2), though consistently achieving such a 
limit of detection would be rare in practice. However, it 
is desirable to detect parasite densities below the com-
mon limits of clinical microscopy in studies performed 
with human subjects to detect persisting or recurrent 
infections as early as possible during follow-up and also 
in studies assessing diagnostic tools, some of which may 
have a lower limit of detection than routine microscopy 
[5, 6]. It is clear that many asymptomatic infections occur 
at densities which are lower than those that can be reli-
ably detected even by skilled microscopists [22–24]. 
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Manual light microscopy is not aimed at detecting or 
excluding such infections for which other tools such as 
nucleic acid amplification tests are needed.
Parasite density estimates can be calculated by count-
ing the numbers of parasites per a set number of HPFs 
or can be based on counts of parasites and WBCs on the 
thick film, or parasites and RBCs on the thin film [25]. 
These are most accurate when the actual WBC or RBC 
count from a concurrently collected blood sample is used 
in the calculation of parasite density [26]. A minimum of 
200 WBCs are usually counted on thick films where par-
asites are detected, increasing up to 500 WBCs in cases 
of low or scanty parasitaemia (< 10 parasites counted per 
200 WBC) [7]. Stochastic and systematic variations in 
parasite density estimates can be reduced with some sim-
ple modifications of the standard procedures such as bas-
ing both parasite detection and counting on either WBC 
or HPF counts (as opposed to HPF counts for detection 
and WBC counts for density estimates) or by always 
counting parasites against a minimum of 500 WBCs or 
40 HPF (see Table 3-A). This would increase the number 
of fields ‘sampled’ from the thick film for parasite counts 
and also allows for those fields or WBCs seen before the 
first parasite is detected to be taken into account in para-
site density calculations (if a parasite is first detected after 
counting 1900 WBCs or checking 150 HPFs, the parasite 
count would be reported as 1 parasite per 1900 WBC or 
150 HPF). It is important to note here that the limit of 
detection or the parasite density in parasites per µL may 
be significantly different between patients or even within 
the same patient over time if indexed to WBC counts. For 
example, counting 2500 WBC corresponds to examina-
tion of 0.5 µL in a subject with 5000 WBC/µL and only 
0.25 µL in a subject with 10,000 WBC/µL, both of which 
are within the common range for WBC counts. This 
variability can be minimized by preparing and staining 
standard slides as described above and by following pro-
cedures based on HPF counts for parasite detection and 
density estimation [20, 25, 27]. In either case, high to very 
high densities (e.g. > 20 parasites per HPF or > 0.3% par-
asitaemia) are best assessed on the thin film (by count-
ing parasites against 2000 RBCs; see Table 3-B) as there 
may be too many parasites on the thick film for accu-
rate counts to be obtained [7]. Secondary morphological 
characteristics are also more clearly seen on the thin film 
Fig. 1 Recommended procedural adjustments to reduce variability in the detection, identification and quantification of malaria parasites by 
microscopy. The size of the thick film in printed versions of the template above must be verified before use
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which can aid parasite species identification even if the 
parasite density is too low for counting on the thin film.
Results reported from malaria microscopy need to 
indicate clearly whether or not parasites are detected, 
and if the presence of parasites is confirmed, the spe-
cies and stages (e.g., asexual and sexual forms or rings 
and schizonts as required by the objectives of the study) 
of the parasites along with a parasite count against HPFs 
or WBCs. Depending on the requirements of the study, 
microscopists may choose to count parasites separately 
by species and stages, each against at least 40 HPFs or 
500 WBCs. If parasites are seen after the first 40 HPFs 
or 500 WBCs, counting may be stopped and the results 
reported per the exact number of HPFs viewed or WBCs 
counted. It may be difficult to distinguish species of indi-
vidual parasites on the thick film, especially at low densi-
ties, and the parasite counts in mixed infections can be 
combined for reporting but each detected species should 
be clearly indicated. Depending on the requirements 
of the study, gametocytes may need to be reported and 
counted, whereas schizonts are counted along with other 
asexual parasite forms (Box 4). In all cases however, para-
site counts must be reported as raw data for conversion 
into parasite densities (see Table  4 for an example of a 
reporting format compliant with the Clinical Data Acqui-
sition Standards Harmonization format from the Clinical 
Data Interchange Standards Consortium) [28].
BOX 4: Standard parameters for blood film examination 
and parasite counting
• Slides must be examined at 1000× magnification 
using immersion oil and adapted objective lenses.
• A minimum of 200 HPFs must be examined or 
2500 WBCs counted on the thick film before declaring 
a slide negative.
• Clearly defined criteria must be consistently 
applied to thick and thin films to count parasites for 
density estimation (e.g., if parasite density is > 20 para-
sites per HPF or > 2 parasites per WBC, parasite den-
sity estimation must be performed using the thin film).
• Parasites must be counted in a minimum of 40 
HPFs or against 500 WBCs in the thick film or against 
2000 RBCs in the thin film.
• Results must be reported as raw figures, i.e. species 
of parasites, the number of asexual or sexual forms 
of the parasite over the number of WBCs or fields 
counted.
• The most recently measured actual WBC or RBC 
counts for the study subject must be used for parasite 
density estimation.
Quality assurance
Quality control (QC), which in the context of microscopy 
usually means re-checking of slides already examined by a 
microscopist, is a critical component of any quality manage-
ment system since it provides feedback on the quality of out-
comes obtained from routine processes implemented under 
everyday conditions. For malaria microscopy, QC must also 
include assessments of the quality of blood films and stain-
ing as poor quality slides can directly affect the ability of the 
microscopist to detect, identify and count parasites. Devia-
tions from pre-defined tolerances can help to identify needs 
for adjustments or refinements to established procedures 
and corrections to individual outcomes, while also indicat-
ing if more rigorous QC protocols are required. In malaria 
microscopy, such tolerance limits have been defined for 
detection, identification and estimation of parasite den-
sity and are described below. These limits have also been 
defined in Box 5 along with recommendations on numbers 
or proportions of slides to be rechecked for IQC and EQC. 
It stands to reason that a higher proportion of slides would 
need to be rechecked if the initial microscopy is performed 
by inexperienced or uncertified microscopists, but a cer-
tain minimum must be maintained to monitor the quality 
of microscopy. QC protocols must be carefully designed to 
address the particular needs of the study while adhering to 
the minimum standards defined below and must take into 
account blood film and staining quality. The results from 
such quality checks can be used to monitor the performance 
of individual microscopists by comparing their results with 
the reported consensus results and, depending on their per-
formance, to adjust the proportions of slides to be reread. 
External QC performed by certified assessors provides an 
additional check of conformity to the standards required 
for research malaria microscopy and can detect systematic 
errors or those which are made by all microscopists at a site.
Definitions of acceptable tolerance in the detection 
and identification of parasites are straightforward—if 
results from two independent reads on the same slide are 
not in agreement with respect to the presence of para-
sites or their species then a tiebreaker read is needed. 
Defining the tolerance for variations in parasite density 
requires more sophisticated methods. The implementa-
tion of such QC criteria or protocols can be facilitated 
and made systematic by using computing aids which 
standardize the thresholds for cross-checking by a third 
microscopist and acceptance criteria for managing out-
lying results across studies, producing more predictable 
variances when comparing paired reads for concordance 
[29–31]. The Obare Method Calculator, for example, 
assesses the probability of observing the two estimated 
densities (given at least one of the two has a density > 200 
parasites/µL) if both were random samples from the the-
oretical distribution of densities with mean equal to the 
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mean of the two estimates. If this probability is < 10%, the 
paired reads are identified as being discordant and a third 
read is required. Other methods, based on calculations of 
the difference in the square roots of the reads or on pro-
portional differences of reads from their mean have also 
been previously described and could be adequate to iden-
tify slides requiring third reads.
BOX 5: Guidelines for internal and external quality control 
(IQC and EQC) of malaria microscopy
• All microscopists performing QC reads must be 
blinded to the slide details as well as the initial results.
• QC checks performed prior to the initial examina-
tion of the slide and during re-checking must include 
assessments of slide quality per standard criteria. The 
slide(s) must be rejected if any issues that could affect 
parasite detection and/or counting are identified (e.g., 
excessive artefacts or stain precipitate, non-standard 
stain or pH interfering with parasite detection and/or 
identification, fixed or patchy thick films).
• IQC: minimum 20% of all study slides, randomly 
selected, re-read for IQC; in case the study microsco-
pists have been certified at Competency Levels 3 or 
4, or are uncertified, up to 100% double-reads may be 
required depending on QC results.
• Results from paired reads from the same slide are con-
sidered discrepant and require a third tie breaker read if:
• Only one microscopist detects parasites;
• The species of the parasites reported by the 
microscopists is (are) different;
• The difference in parasite density for asexual par-
asites is greater than a pre-defined limit (e.g. per the 
Obare Method Calculator, ‘square mean root count’ 
method [29], or a   % difference from the mean of 
the two reads). An exception is when both estimates 
are ≤ 200/µL, in which case both parasite density esti-
mates are considered to be within accepted ranges 
of variability as long as both detect parasites. Sexual 
forms and schizonts can be reported separately but, 
depending on the study’s needs, may or may not need 
to be considered in assessments of discordance.
• EQC: 5 positive and 5 negative slides per micros-
copist per month or ≥ 5% of all slides if > 200 slides 
read per month, randomly selected, to be re-read by 
external assessors with certified  Level 1 Competency.
Recording and reporting microscopy results
To enable useful interpretation of results and compari-
sons with other studies, standardized reporting of the 
results and methods used for microscopy is essential, 
whether the microscopy is the primary subject of the 
study or a standard against which other assays are com-
pared. Standardized recording of microscopy results may 
be easily implemented by using case record forms com-
pliant with the Clinical Data Acquisition Standards Har-
monization [28]. Further, reports involving microscopy 
should clarify the competence of the microscopists, tech-
nical specifications of the microscope and the methods 
and reagents used, all of which contribute to accuracy 
of slide interpretation (Box 6). A description of the qual-
ity assurance processes in place must also be reported 
alongside the QC results which help to demonstrate the 
reliability of the results presented.
BOX 6: Suggested minimum requirements for reporting 
malaria microscopy procedures and results in clinical 
research publications
• Blood sample collection method (fingerprick or 
venepuncture).
• Source of Giemsa stain stock solution.
• Microscope specifications and/or brand, model.
• Number of fields examined before declaring slide 
negative.
• Parasite density estimation method (‘WBC’ or 
‘HPF’); WBC, RBC counts used in calculations (actual 
or assumed counts).
• QC protocols (competency testing done by 
microscopists if any, proportion of slides double-read, 
criteria for tie-breaker reads, proportion of slides 
rechecked for external quality control, competency 
level of reference microscopist).
• QC results (as compared to reference micros-
copy—Se, Sp, kappa for species, proportion of slides 
with discordant parasite density as detected by exter-
nal rechecking).
Table 2 Variations in counting parameters with differences in the Field Number (FN) of the ocular lens
Values calculated assuming a standard thick film made with 6 µL of blood evenly spread over a circle of 12 mm diameter [11]
Field number 18 20 22 26.5
Area of HPF  (mm2) 0.0255 0.0314 0.0380 0.0552
Volume of blood per HPF (µL) 0.00135 0.00167 0.00202 0.00293
Volume of blood per 200 HPFs (µL) 0.270 0.333 0.403 0.585
Mean WBC/HPF (assuming 8000 WBC/µL) 11 13 16 23
Page 10 of 14Dhorda et al. Malar J          (2020) 19:324 
Table 3 Impact of stochastic variation when estimating parasite density from thick or thin films with nominated parasite 
density. Results from simulations of counting parasites on thick films against 200 WBC and 500 WBC (assuming 8000 WBC 
per µL; (A)) or on a thin film per 1000 RBC and 2000 RBC (assuming 5 × 106 RBC per µL; (B)). Parasite density estimates 
obtained from a single read by counting parasites per 500 WBC or 2000 RBC tend to be closer to the actual density. When 
the parasite density is estimated from two readings, fewer paired reads are discordant per Obare criteria [30]. Parasite 
density estimates were defined as  being discordant if  there is  a < 10% chance of  observing the  two read densities 
if  both  were random samples from  the  theoretical probability distribution with  mean equal to  the  average of  the  first 
and  second read densities, given  that  at least one of  the  first or  second reads has  a  density for  a  particular species 
above 200 parasites/µL
True parasite density (parasites/µL)
200 250 500 1000 5000 10,000 16,000
(A) Thick film counts
Against 200 WBC
Distribution of single read (n = 1000)
Mean (sd) 199.8 (89.1) 250.8 (101.6) 496.7 (138.9) 983.5 (200.1) 5018.5 (565.1) 10,041.7 (904.6) 16,001.9 (1357.9)
25th and 75th 
percentiles
120 and 261 189 and 314 396 and 585 839 and 1121 4619 and 5397 9412 and 10,624 15,080 and 16,956
5th and 95th 
percentiles
76 and 355 82 and 429 272 and 731 673 and 1320 4121 and 5989 8610 and 11,604 13,822 and 18,339
Simulation of 2 microscopy readings (n = 10,000)
% with both 
read-
ings ≤ 200/uL
34.3 13.9 0.02 0.0 0.0 0.0 0.0
% requiring 3rd 
read (Obare 
criteria)
12.7 15.4 15.3 15.4 23.1 28.7 36.9
Against 500 WBC
Distribution of single read (n = 1000)
Mean (sd) 199.7 (57.0) 248.9 (64.5) 499.5 (89.2) 998.3 (133.8) 5004.5 (354.2) 9995.1 (579.5) 15,964.0 (883.0)
25th and 75th 
percentiles
158 and 238 204 and 287 441 and 559 910 and 1085 4756 and 5247 9607 and 10,372 15,395 and 16,556
5th and 95th 
percentiles
112 and 300 144 and 365 351 and 648 780 and 1213 4441 and 5605 9076 and 10,992 14,534 and 17,524
Simulation of 2 microscopy readings (n = 10,000)
% with both 
read-
ings ≤ 200/µL
25.3 4.9 0.0 0.0 0.0 0.0 0.0
% requiring 3rd 
read (Obare 
criteria)
1.9 3.0 2.5 2.8 5.5 9.8 16.9
True parasite density (parasites/µL)
16,000 20,000 32,000 64,000 128,000 200,000 250,000
(B) Thin film counts
Against 1000 RBC
Distribution of single read (n = 1000)
Mean (sd) 16,328.4 (8892.7) 19,979.2 (9541.3) 32,539.0 
(12,592.1)
63,489.3 
(17,600.1)
127,011.1 
(23,853.1)
200,712.7 
(32,038.7)
252,236.6 
(33,445.7)
25th and 
75th  %iles
9609 and 22,386 13,915 and 
24,919
23,747 and 
39,969
51,450 and 
75,794
110,391 and 
142,273
179,076 and 
221,459
229,845 and 
274,556
5th and 
95th  %iles
4617 and 33,049 4818 and 37,912 14,020 and 
53,447
34,967 and 
93,502
89,799 and 
168,045
147,499 and 
254,466
194,879 and 
306,865
Simulation of 2 microscopy readings (n = 10,000)
% requiring 3rd 
read (Obare 
criteria)
11.5 12.1 13.6 14.5 11.9 14.5 10.6
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Discussion
The Research Malaria Microscopy Standards (ReMMS) 
presented here, complemented by the ReMMS Manual 
and the Obare Calculator research microscopy stand-
ardization tool, are an attempt to make a set of standards 
and procedures freely available to the malaria research 
community, aimed at increasing the consistency and 
reliability of malaria microscopy performed for research 
studies (see Box  6) [11, 30, 32]. This is a vital and nec-
essary step towards harmonizing the methods used in 
malaria studies which will allow data obtained over time 
and/or across diverse contexts to be compared directly, 
thus multiplying the impact of and confidence in stud-
ies assessing drug or vaccine efficacy or the performance 
of new diagnostic tools. While certain points in these 
standards and procedures are highlighted as being criti-
cal to maintaining consistency, it is hoped that there is 
enough flexibility to accommodate the particularities of 
diverse study types and that they will be widely adopted. 
They provide the core of a quality management system 
and can be used to design programmes for training, pro-
ficiency testing and quality assurance of research malaria 
microscopy.
Many research laboratories have already implemented 
quality management systems for microscopy or for the 
laboratory as a whole. However, a framework, such as 
the one described in the WHO Malaria Microscopy 
Quality Assurance manual for National Malaria Con-
trol Programmes, is lacking for microscopy in research. 
As a result, high-quality training and standard profi-
ciency testing is hard to find outside certain reference 
centres [33]. While this is being addressed, it is hoped 
that researchers will find it worthwhile to review and 
update their existing quality management protocols 
to match the standards described here using currently 
available resources (e.g., WHO Malaria Slide Bank hosted 
by the Research Institute for Tropical Medicine [The 
Philippines], Malaria Research and Reference Reagent 
Resource Center [USA], slide exchanges with collaborat-
ing or partner laboratories) for testing the proficiency of 
their microscopists. It would be hard to over-emphasize 
the importance of the high level of motivation and com-
mitment needed from microscopists and their manage-
ment to attain and maintain these standards. This process 
would be facilitated by ensuring the availability of train-
ing on the techniques and by recognizing the importance 
of workload management, feedback on performance and 
support for improvement where needed. These are all 
factors that should be part of a well-functioning quality 
management system and will need to be in place if labo-
ratories are to attain the goal of certification of micros-
copists and accreditation of the microscopy laboratory. 
Without sufficient effort to ensure high standards and 
repeatability of microscopy results within field study 
design, the effort and resources employed, and the sup-
port of study subjects is greatly devalued.
Microscopy on Giemsa-stained blood films to detect, 
identify and quantitate malaria parasites is a technique 
which is already more than a century old and may be 
replaced in the future by methods based on polymerase 
chain reaction (PCR) or machine learning for micro-
graphic image analysis for research and clinical applica-
tions [34, 35]. PCR-based methods have the advantage of 
being less dependent on human interventions for inter-
preting and reporting of results but are typically more 
demanding in terms of human and material resources, 
training and quality assurance. They may require signifi-
cant investment into robust logistics to transport sam-
ples to a central laboratory or for equipping peripheral 
laboratories with PCR equipment, or both, and have their 
Table 3 (continued)
True parasite density (parasites/µL)
16,000 20,000 32,000 64,000 128,000 200,000 250,000
Against 2000 RBC
Distribution of single read (n = 1000)
Mean (sd) 16,116.9 (6051.3) 20,140.1 (6869.9) 3773.0 (9055.7) 64,819.4 
(12,493.7)
128,216.7 
(17,857.2)
199,747.5 
(22,125.0)
249,103.6 
(25,238.4)
25th and 
75th  %iles
11,872 and 
19,666
15,956 and 
24,070
25,668 and 
37,926
56,610 and 
72,317
115,908 and 
140,332
183,871 and 
215,118
231,741 and 
265,957
5th and 
95th  %iles
7076 and 26,527 9397 and 31,699 18,248 and 
47,561
45,282 and 
86,739
99,791 and 
159,231
164,356 and 
235,178
209,136 and 
291,824
Simulation of 2 microscopy readings (n = 10,000)
% requiring 3rd 
read (Obare 
criteria)
2.5 3.1 4.6 3.7 3.5 3.3 3.5
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own challenges with respect to standardization between 
laboratories [36]. Turn-around times for results may be 
higher due to requirements for batch processing to con-
serve reagents making it difficult to use PCR-based test-
ing for screening symptomatic patients or for follow-up. 
Further, quantification of parasite density is complicated 
by multinucleate forms of the parasite (mostly for non-
falciparum species) and by the requirement for separate 
RT-PCRs required for gametocyte detection. Overall, a 
wealth of information, including that on other concurrent 
blood-borne parasites or haematological parameters, can 
be obtained from correctly performed microscopy. Such 
analyses can also be performed by PCR-based or other 
technologies but at a much higher complexity and cost.
Conclusion
The standards described here (Fig. 1) and the accompa-
nying manual were developed to guide a move towards 
common standards for undertaking and reporting 
research microscopy for malaria parasite detection, 
identification and quantification. These documents are 
based on agreed quality assurance standards for research 
malaria microscopy defined by participants in an infor-
mal consultation convened by the Special Programme 
for Research and Training in Tropical Diseases (TDR). 
The participants jointly recognized a need to standard-
ize research microscopy to improve the quality of clini-
cal and diagnostic trials, enable comparisons of outcomes 
between clinical trials, and provide clarity in publication. 
Table 4 Reporting format for malaria microscopy data
MICROSCOPY MBCAT = MALARIA MICROSCOPY
REPEAT AS PER PROTOCOL
Collection date and time
MBDAT MBDTC
Reader 
number
a
MBEVA
LID
Slide 
quality
SDQUAL
Film type
MBMETHO
D
Parasite 
typeb
MBTEST
CD/
TEST
Parasite 
countc
MBORRES 
Parasite count unitsd
MBORRESU
Malaria speciese
MBTESTCD/TEST
|__|__|-|__|__|__|-
|__|__|__|__|
Good 
Poor
Thick film 
Thin film
Asexual
Sexual
|__|__|__|__|
/_____W /_____HP /_____RB
Pf       Pv      
Po
|__|__|:|__|__| MBTIM 
MBDTC
Missing BC F C Pm     Pk
|__|__|-|__|__|__|-
|__|__|__|__|
|__|__|:|__|__| MBTIM
MBDTC
Good 
Poor
Missing
Thick film 
Thin film
Asexual
Sexual
|__|__|__|__| /_____W
BC
/_____HP
F
/_____RB
C
Pf       Pv      
Po
Pm     Pk
|__|__|-|__|__|__|-
|__|__|__|__|
|__|__|:|__|__| MBTIM
MBDTC
Good 
Poor
Missing
Thick film 
Thin film
Asexual
Sexual
|__|__|__|__| /_____W
BC
/_____HP
F
/_____RB
C
Pf       Pv      
Po
Pm     Pk
Clinical Data Acquisition Standards Harmonization (CDASH) annotations are in italics; Standard Data Tabulation Module (SDTM) annotations are underlined
a For studies that require the slide to be read by more than one microscopist, include a separate row for the results from each reader
b Complete a separate row for asexual and sexual parasites if seen on the same slide. Adapt if additional information on the staging of asexual parasites may be 
required by the study protocol; e.g. rings, trophozoites, schizonts
c Record the actual parasite count per WBC/HPF/RBC; conversion into parasites per µL are performed separately
d The preferred method of calculating parasite density uses actual WBC/μL; some study protocols may assume (xxx) WBC/μL or use the ‘HPF’ method
e In cases of mixed infections, all infecting species must be reported; however, the asexual and/or sexual parasite count need not be reported separately for each 
species unless specifically required in the study protocol. If species are reported separately, counts for each species must be entered on separate lines. Asexual and 
sexual stages from the same slide/parasite species also must be entered on separate lines
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It is hoped that this summary, together with the Manual 
it describes and the accompanying Obare Calculator, will 
form a solid basis for the wider adoption of standardized 
reference microscopy protocols for malaria research.
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